Lotte Shopping Co.'s first-quarter net losses narrowed from 43.3 billion won last year to 40.6 billion won this year on recovering department store sales.
Consumer sentiment for luxury goods recovered after a year into the coronavirus pandemic.
However, sales remain sluggish at Lotte's large discount store chains and supermarket chains.
The retail giant's operating income soared 18.5 percent to 61.8 billion won in the first quarter from last year's 52.1 billion won.
Sales dropped 4.8 percent from 4.07 trillion won last year to 3.88 trillion won this year.
The company's operating profit was 57.1 percent lower than the average estimate.
Shares in Lotte Shopping, operator of South Korea's biggest department store outlets, rose 2.78 percent to 129,500 won on the Seoul bourse, outperforming the 1.63 percent gain at KOSPI.


Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Instagram Outage Disrupts Thousands of U.S. Users
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



